login
login

Europe Daily Bulletin No. 12572

2 October 2020
EU RESPONSE TO COVID-19 / Health
AstraZeneca’s candidate vaccine under ongoing review by European Medicines Agency

01/10/2020 (Agence Europe)The European Medicines Agency (EMA) announced on Thursday 1 October that it has begun an ongoing review of data related to the candidate vaccine developed by AstraZeneca in collaboration with Oxford University. The decision of the EMA, and more specifically its Committee for Medicinal Products for Human Use, is based on preliminary results of non-clinical and early clinical studies suggesting that the vaccine triggers the production of antibodies and T cells...

Contents

EUROPEAN COUNCIL
EU RESPONSE TO COVID-19
SECTORAL POLICIES
EXTERNAL ACTION
SECURITY - DEFENCE
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
COURT OF JUSTICE OF THE EU
NEWS BRIEFS